Response observed during treatment for amyloid a (AA) amyloidosis with eprodisate (NC-503; 1,3-propanedisulfonate) after 2 years in patients with familial mediterranean fever in comparison to patients with rheumatoid arthritis.
dc.contributor.author | Benson, M. D. | |
dc.contributor.author | Hauck, W. | |
dc.contributor.author | Merlini, G. | |
dc.contributor.author | Hazenberg, B. P. C. | |
dc.contributor.author | Garceau, D. | |
dc.contributor.author | Livneh, A. | |
dc.contributor.author | Gorevic, P. D. | |
dc.contributor.author | DİRESKENELİ, RAFİ HANER | |
dc.contributor.author | GÜL, Ahmet | |
dc.contributor.author | Ozdogan, H. | |
dc.contributor.author | Hawkins, P. N. | |
dc.contributor.author | Dember, L. M. | |
dc.contributor.author | Hachulla, E. | |
dc.date.accessioned | 2022-02-18T09:38:14Z | |
dc.date.available | 2022-02-18T09:38:14Z | |
dc.identifier.citation | Livneh A., Gorevic P. D. , DİRESKENELİ R. H. , GÜL A., Ozdogan H., Hawkins P. N. , Dember L. M. , Hachulla E., Merlini G., Benson M. D. , et al., "Response observed during treatment for amyloid a (AA) amyloidosis with eprodisate (NC-503; 1,3-propanedisulfonate) after 2 years in patients with familial mediterranean fever in comparison to patients with rheumatoid arthritis.", 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4f1166d8-af39-4d34-bf0a-11646286e01b | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/177632 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Rheumatology | |
dc.subject | Health Sciences | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.subject | Tıp | |
dc.title | Response observed during treatment for amyloid a (AA) amyloidosis with eprodisate (NC-503; 1,3-propanedisulfonate) after 2 years in patients with familial mediterranean fever in comparison to patients with rheumatoid arthritis. | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 54 | |
dc.contributor.firstauthorID | 3141889 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]